Alector, a biomedical company, underperformed the S&P 500 market gain on August 8, 2025.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alector, a biomedical company, underperformed the S&P 500 market gain on August 8, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alector (United States)
company in San Francisco, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksAlector (ALEC) Reports Q2 Loss, Tops Revenue Estimates Alector (ALEC) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to a loss